Restricted accessLetterFirst published online 1998-7
Transforming Growth Factor Beta 2 (TGFß2) and Dehydroepiandrosterone Sulphate (DHEAs) Levels in Breast Macrocyst Fluids. Different Behaviour According to Cyst Type
CiattoS., BiggeriA., Rosselli del TurcoM., BartoliD., IossaA.Risk of breast cancer subsequent to proven gross cystic disease.Eur J Cancer1990; 26: 555–7.
2.
DixonJ.M., LumsdenA.B., MillerW.R.The relationship of cyst type to risk factors for breast cancer and the subsequent development of breast cancer in patients with breast cystic disease.Eur J Cancer Clin Oncol1985; 21: 1047–50.
3.
NessJ.C., SedghinasabM., MoeR.E., TapperD: Identification of multiple proliferative growth factors in breast cyst fluid.Am J Surg1993, 166: 237–43.
4.
ZanardiS., PensaF., TorrisiR.Presence and distribution of growth factors in breast cyst fluid.Ann NY Acad Sci1996; 784: 542–9.
5.
BoccardoF., ValentiG., ZanardiS., CerrutiG., FassioT., BruzziP.Epidermal growth factor in breast cyst fluid: relationship with intracystic cation and androgen conjugate content.Cancer Res1988; 48: 5860–3.
6.
MillerW.R., DixonJ.M., ScottW.N., ForrestA.P.M.Classification of human breast cysts according to electrolyte and androgen conjugate composition.Clin Oncol1983; 9: 227–32.
7.
BassiF., GiustiG., BorsiL., CattaneoS., GianottiP., FortiG.Plasma androgen in women with hyperprolactinemic amenorrhea.Clin Endocrinol1977; 6: 5–11.
8.
VizosoF., FueyoA., AllendeM.T., FernándezJ., García MoranM., RuibalA.Evaluation of human breast cysts according to their biochemical and hormonal composition and cytologic examination.Eur J Surg Oncol1990; 16: 209–14.
9.
LaiL.C., SirajA.K., ErbasH., LennardT.W.Relationship between basic fibroblastic growth factor and transforming growth factor beta 2 in breast cyst fluid.J Clin Endocrinol Metab1995; 80: 711–4.
10.
LaiL.C., SirajA.K., ErbasH., LennardT.W.Transforming growth factor alpha, beta 1 and beta 2 in breast cyst fluid.Anticancer Res1994; 14: 2805–9.
